Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
A fast and powerful way to end firefighting, frustration and friction.
As organisations grow, they also grow in complexity. Teams become busier, priorities multiply, and decision-making gets harder. Leaders feel like they are firefighting symptoms without ever getting to the root cause.
This is the second event in a three-part event series which will help growing ventures understand and develop compliance foundations that investors expect. This session will be held in-person only.
Early-stage companies such as those in life-sciences operate in one of the most opportunity-rich—and heavily scrutinised—sectors in the UK. As they grow, seek investment, partner with strategic corporates, or prepare for acquisition, investors and financing banks will expect credible, proportionate governance foundations that protect and create value, and minimise avoidable risk.
Celebrate the opening of one of Cambridge’s newest science parks, the Press, based in Foxton, Cambridgeshire with a lifescience fireside chat about AI in healthcare with two excellent speakers. There’ll be lots of networking opportunities afterwards and a chance to see the new park.
Our speakers for the evening will be:
LONDON, UK and CAMBRIDGE, MA – January 13, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for Trevi Therapeutics, Inc. (Nasdaq: TRVI) and is pleased to announce the placement of David Hastings as Chief Financial Officer (CFO).
Amsbio announces a new range of well characterized Adeno-Associated Virus (AAV) reference standards that enable researchers to significantly improve their AAV production processes.
Experienced operational leader across medical research and deep tech appointed to support sustainable growth as part of Qureight’s strategy to scale company operations
Cambridge, UK, 12 January 2026 – Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered CT imaging biomarkers and clinical data management platform in clinical trials, today announced the appointment of Rebecca Simmons as Chief Operating Officer.
Nordic Life Science Days is the largest life science partnering event in the Nordics. NLSDays gathers big pharma executives, investors and CEOs of biotech, pharma and medtech companies and discusses the road ahead for the life science industry. 2025 numbers: • Attracted 1600+ delegates from 32 countries.